GoodRx to be barred from sharing wellbeing info for advertisements below proposed FTC settlement

GoodRx to be barred from sharing wellbeing info for advertisements below proposed FTC settlement


GoodRx signage on the outside the house of the Nasdaq on the working day of its IPO, September 23, 2020.

Supply: GoodRx

The Federal Trade Commission proposed to forever bar prescription drug comparison web page GoodRx from sharing users’ well being information with 3rd functions for promoting applications, the agency explained Wednesday.

In a “initial-of-its-form proposed purchase,” the FTC also claimed it’s imposing a $1.5 million civil penalty for allegedly violating the agency’s Health and fitness Breach Notification Rule. Below the settlement, GoodRx is demanded to limit how extended it holds on to particular and health and fitness data of people, and to talk to 3rd get-togethers to delete purchaser wellbeing details shared with them.

The FTC alleged GoodRx shared personal wellness details, including person prescription remedies and particular health ailments, with companies like Facebook, Google and Criteo given that at least 2017, regardless of promises not to give consumer information to advertisers or 3rd get-togethers. The company also claims GoodRx made use of personalized health and fitness data to target its buyers with individualized ads on Fb and Instagram. For case in point, according to the FTC, GoodRx in 2019 uploaded to Fb a list of information from buyers, who purchased certain prescription drugs, in order to focus on them with advertisements.

GoodRx claimed in a press release that it disagrees with the FTC’s allegations and doesn’t acknowledge wrongdoing. It claimed that the settlement will allow the enterprise to keep away from expensive and time-consuming litigation and that the arrangement “will have no substance effect on our business enterprise.”

“The settlement with the FTC focuses on an outdated situation that was proactively tackled nearly 3 years in the past, just before the FTC inquiry started,” GoodRx stated, adding that it manufactured updates to safeguard consumer security right before it was contacted by the agency.

GoodRX shares have been up 3.5% on Wednesday to $5.79. The stock has misplaced more than three-quarters of its value in the earlier calendar year.

GoodRx mentioned in a site publish that health care records have been not shared by means of its use of the Facebook pixel, the code websites use for advertising and marketing. Even so, GoodRx claimed, it “led the sector by taking away the standard Fb Javascript pixel practically three decades ago.”

FTC Commissioners voted 4- to refer the proposed buy to the Office of Justice to file it on the FTC’s behalf.

Subscribe to CNBC on YouTube.

Check out: The modifying experience of privacy in the pandemic

The changing face of privacy in a pandemic



Source

Qualcomm stock sinks 10% as company issues dire warning on memory shortage
Technology

Qualcomm stock sinks 10% as company issues dire warning on memory shortage

Qualcomm CEO Cristiano Amon delivers a keynote speech at Computex in Taipei, Taiwan, May 19, 2025. Ann Wang | Reuters Qualcomm shares plunged 10% after the chipmaker issued disappointing guidance as skyrocketing demand for artificial intelligence data centers eats away at memory chip supply for consumer electronics. On an earnings call with analysts, Qualcomm CEO […]

Read More
Super Bowl AI ad spat heats up as Altman lashes out at Anthropic campaign
Technology

Super Bowl AI ad spat heats up as Altman lashes out at Anthropic campaign

Sam Altman, chief executive officer of OpenAI Inc., during a media tour of the Stargate AI data center in Abilene, Texas, US, on Tuesday, Sept. 23, 2025. Kyle Grillot | Bloomberg | Getty Images After Anthropic took aim at OpenAI’s ad push in a new Super Bowl campaign on Wednesday, OpenAI CEO Sam Altman shared a […]

Read More
OpenAI launches new enterprise platform in bid to win more business customers
Technology

OpenAI launches new enterprise platform in bid to win more business customers

Sam Altman, CEO of OpenAI, is pictured on Sept. 25, 2025, in Berlin. Florian Gaertner | Photothek | Getty Images OpenAI on Thursday announced a new enterprise platform called Frontier, its latest launch as part of its ongoing effort to win more business customers. Frontier acts as an intelligence layer that stitches together disparate systems […]

Read More